Eli Lilly offers doses of higher weight weight loss drugs in Lillydirect

Eli Lilly On Tuesday, he released higher doses of his drug to lose weight in unique dose roads up to half of his usual monthly list price to reach more patients without insurance coverage for great success injection, such as those with Medicare.

It expands the company’s effort to boost the US offer.

Eli Lilly now offers higher dose of zero in unique dose roads through a section of “paid car payment pharmacy” on its direct website to the consumer, Lillydirect, which began offering lower doses of drugs in vials in August. Eldible patients diagnosed by a medical care provider with obesity alone or together with the obstructive sleep apnea-zepbound’s Newly approved use – You can pay for those roads themselves on the site.

The company is selling 7.5 milligrams and 10 vials of milligrams of Zepbound for $ 499 per month when patients fill their first recipe, and every time they are filled within 45 days after their previous delivery. Otherwise, these two doses will cost $ 599 and $ 699, respectively.

Also on Tuesday, Eli Lilly said that the price of the two lower dose roads of Zepbound is lower A statement.

Patients should use a syringe and a needle to extract the medication from a unique dose road and inject. That differs from a single dose The injector car thinksThe currently available shape of all Zepbound doses, which patients can inject directly under their skin with clicking a button.

Eli Lilly has said that those roads Make more of the medications available Because they are easier to manufacture than the autoinjector pens, which cost approximately $ 1,000 per month before insurance.

Patients generally begin treatment with a 2.5 milligrams dose for four weeks, then gradually increase the amount per week and then take the so -called maintenance dose to maintain the weight. Eli Lilly does not currently offer the higher doses of Zepbound-12.5 milligrams and 15 milligrams-in unique dose roads.

The lowest price points for each of the unique dose roads will benefit patients who are willing to pay for zero and enroll in health plans sponsored by Medicare or sponsored by the employer who do not cover obesity treatments.

“We are, in the absence of total coverage for people who suffer from obesity like other chronic diseases, we are only trying to fill that room and provide a more affordable solution, particularly for the population of Medicare because none of our affordability solutions can apply “said Patrik Jonsson, president of Diabetes and Obesity of Eli Lilly, in an interview.

Medicare beneficiaries are not eligible for Eli Lilly savings card programs for ZEPBOUND. Jansson said “In an ideal world,” the Trump administration will promulgate a proposed rule of the Biden Administration to Medicare cover the medications for obesity. The Secretary of the Department of Health and Human Services of the United States, Robert F. Kennedy Jr., has been skeptical of weight loss drugs.

Some people turned to aggravating pharmacies that make even cheaper copies of Zepbound because brand treatment has been too expensive and was scarcity until recent months. The United States Food and Medicines Administration has since declared However, Zepbound’s scarcity in excess, which will soon prevent many compound pharmacies when making those versions of the medication.

Jansson said Eli Lilly “is not competing with the price with the compounds,” and added that the company does not believe that “there is still a market for the mass compound.”

He said that Tuesday’s announcement helps to ensure that patients “do not trust imitations that are not approved by FDA for safety, efficiency and quality.”

In December, the direct medical care startup said that its platform It will also offer unique dose roads of Zepbound through a new association With Eli Lilly.